DART: DUAL ANTI-CTLA-4 AND ANTI-PD-1 BLOCKADE IN RARE TUMORS

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Advanced Rare Tumors
  • Age: Between 18 - 99 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Patients must have histologically confirmed rare cancer. 2. No other prior malignancy is allowed except for the following: Adequately managed Stage I or II cancer from which the patient is currently in complete remission OR Any other cancer from which the patient has been disease free for one year OR Adequately managed Stage I or II follicular thyroid or prostate cancer

You may not be eligible for this study if the following are true:

  • 1. Patients with active autoimmune disease 2. Patients with uncontrolled intercurrent illness


If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.